Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

Plans and Pricing

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: atovaquone; proguanil hydrochloride

« Back to Dashboard
Atovaquone; proguanil hydrochloride is the generic ingredient in three branded drugs marketed by Glenmark Generics, Mylan Pharms Inc, and Glaxosmithkline, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for atovaquone; proguanil hydrochloride. Five suppliers are listed for this compound.

Summary for Generic Name: atovaquone; proguanil hydrochloride

Tradenames:3
Patents:0
Applicants:3
NDAs:3
Drug Master File Entries: see list14
Suppliers: see list5
Therapeutic Class:Antiparasitics
Formulation / Manufacturing:see details

Pharmacology for Ingredient: atovaquone; proguanil hydrochloride

Clinical Trials for: atovaquone; proguanil hydrochloride

Single Oral Dose Study of Atovaquone/Proguanil Hydrochloride Combination Tablets and Atovaquone Suspension
Status: Completed Condition: Malaria

The ASAP Study - Therapeutic Efficacy of Atovaquone-proguanil vs. Artesunate-atovaquone-proguanil in Cambodia
Status: Not yet recruiting Condition: Malaria

Chloroquine Alone or in Combination for Malaria in Children in Malawi
Status: Completed Condition: Plasmodium Falciparum Infection

Weekly Dosing of Malarone ® for Prevention of Malaria
Status: Completed Condition: Malaria

Azithromycin Plus Chloroquine Versus Atovaquone-Proguanil For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In South America
Status: Completed Condition: Malaria, Falciparum

Evaluation of Potential Effect of Artemether - Lumefantrine and Malaria Drugs on Auditory Function
Status: Completed Condition: Malaria; Falciparum

Evaluation of the Riamet® Versus Malarone® in the Treatment of Uncomplicated Malaria
Status: Active, not recruiting Condition: Malaria

Drug Interaction Study Between Atovaquone and Antiretroviral Agents in HIV-1 Infected Patients
Status: Completed Condition: HIV Infections; Malaria

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline
MALARONE PEDIATRIC
atovaquone; proguanil hydrochloride
TABLET;ORAL021078-002Jul 14, 2000RXNo<disabled><disabled>
Glenmark Generics
ATOVAQUONE AND PROGUANIL HYDROCHLORIDE
atovaquone; proguanil hydrochloride
TABLET;ORAL091211-001Jan 12, 2011RXNo<disabled><disabled>
Glenmark Generics
ATOVAQUONE AND PROGUANIL HYDROCHLORIDE
atovaquone; proguanil hydrochloride
TABLET;ORAL091211-002Apr 6, 2015RXNo<disabled><disabled>
Mylan Pharms Inc
ATOVAQUONE AND PROGUANIL HYDROCHLORIDE
atovaquone; proguanil hydrochloride
TABLET;ORAL202362-001May 27, 2014RXNo<disabled><disabled>
Mylan Pharms Inc
ATOVAQUONE AND PROGUANIL HYDROCHLORIDE
atovaquone; proguanil hydrochloride
TABLET;ORAL202362-002May 27, 2014RXNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013   2014  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2015 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:

Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn
`abc